Skip to content
10-Q

Quarterly Report

APPLIED GENETIC TECHNOLOGIES CORP

0001193125-22-151743

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · May 12, 2022 50.73M sh
Shares Diluted Q3 2022 · Mar 31, 2022 43.64M sh
Shares Diluted Q3 2022 · Mar 31, 2022 43.11M sh
Shares Diluted Q3 2022 · Mar 31, 2021 36.75M sh
Shares Diluted Q3 2022 · Mar 31, 2021 29.43M sh
Capex Q3 2022 · Mar 31, 2022 $900K
Capex Q3 2022 · Mar 31, 2021 $987K
Operating Cash Flow Q3 2022 · Mar 31, 2022 −$47.49M
Operating Cash Flow Q3 2022 · Mar 31, 2021 −$37.74M
Long Term Debt Q3 2022 · Mar 31, 2022 $11.36M
Long Term Debt Q3 2022 · Jun 30, 2021 $17.73M
Short Term Debt Q3 2022 · Mar 31, 2022 $9.07M
Short Term Debt Q3 2022 · Jun 30, 2021 $2.18M
Cash And Equivalents Q3 2022 · Mar 31, 2022 $67.85M
Cash And Equivalents Q3 2022 · Jun 30, 2021 $105.05M
Stockholders Equity Q3 2022 · Mar 31, 2022 $47.03M
Stockholders Equity Q3 2022 · Dec 31, 2021 $51.49M
Stockholders Equity Q3 2022 · Sep 30, 2021 $69.53M
Stockholders Equity Q3 2022 · Jun 30, 2021 $85.81M
Stockholders Equity Q3 2022 · Mar 31, 2021 $97M
Stockholders Equity Q3 2022 · Dec 31, 2020 $41.52M
Stockholders Equity Q3 2022 · Sep 30, 2020 $56.2M
Stockholders Equity Q3 2022 · Jun 30, 2020 $71.02M
Current Liabilities Q3 2022 · Mar 31, 2022 $25.81M
Current Liabilities Q3 2022 · Jun 30, 2021 $19.71M
Total Liabilities Q3 2022 · Mar 31, 2022 $40.16M
Total Liabilities Q3 2022 · Jun 30, 2021 $41.16M
Current Assets Q3 2022 · Mar 31, 2022 $70.53M
Current Assets Q3 2022 · Jun 30, 2021 $109.71M
Total Assets Q3 2022 · Mar 31, 2022 $87.19M
Total Assets Q3 2022 · Jun 30, 2021 $126.97M
Eps Diluted Q3 2022 · Mar 31, 2022 −$0.33
Eps Diluted Q3 2022 · Mar 31, 2022 −$1.17
Eps Diluted Q3 2022 · Mar 31, 2021 −$0.40
Eps Diluted Q3 2022 · Mar 31, 2021 −$1.55
Eps Basic Q3 2022 · Mar 31, 2022 −$0.33
Eps Basic Q3 2022 · Mar 31, 2022 −$1.17
Eps Basic Q3 2022 · Mar 31, 2021 −$0.40
Eps Basic Q3 2022 · Mar 31, 2021 −$1.55
Sga Expense Q3 2022 · Mar 31, 2022 $4.42M
Sga Expense Q3 2022 · Mar 31, 2022 $12.51M
Sga Expense Q3 2022 · Mar 31, 2021 $3.53M
Sga Expense Q3 2022 · Mar 31, 2021 $10.27M
Rd Expense Q3 2022 · Mar 31, 2022 $9.16M
Rd Expense Q3 2022 · Mar 31, 2022 $35.94M
Rd Expense Q3 2022 · Mar 31, 2021 $10.96M
Rd Expense Q3 2022 · Mar 31, 2021 $34.4M
Net Income Q3 2022 · Mar 31, 2022 −$14.29M
Net Income Q3 2022 · Mar 31, 2022 −$50.56M
Net Income Q3 2022 · Dec 31, 2021 −$19.14M
Net Income Q3 2022 · Sep 30, 2021 −$17.12M
Net Income Q3 2022 · Mar 31, 2021 −$14.85M
Net Income Q3 2022 · Mar 31, 2021 −$45.69M
Net Income Q3 2022 · Dec 31, 2020 −$15.46M
Net Income Q3 2022 · Sep 30, 2020 −$15.38M
Operating Income Q3 2022 · Mar 31, 2022 −$13.58M
Operating Income Q3 2022 · Mar 31, 2022 −$48.45M
Operating Income Q3 2022 · Mar 31, 2021 −$14.49M
Operating Income Q3 2022 · Mar 31, 2021 −$44.67M
Revenue Q3 2022 · Mar 31, 2022 $0
Revenue Q3 2022 · Mar 31, 2022 $0
Revenue Q3 2022 · Mar 31, 2021 $0
Revenue Q3 2022 · Mar 31, 2021 $0
Short Term Investments Q3 2022 · Jun 30, 2021 $2M